A Single Group Study to Evaluate the Efficacy of a Cosmetic Product Line on Acne Symptoms
NCT06122467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2024-03-20
Summary
This twelve-week trial will examine the effectiveness of a Menning Labs EQ Product Line acne product. Participants will use the exfoliating cleanser, cream, and gel daily for 8 weeks. Participants will complete questionnaires at Baseline, Day 1, Day 3, Day 7, Day 28, Day 42, and Day 56. Participants will also provide before-and-after photos at Baseline, Day 7, and Day 42, as well as undergo expert skin grading at Baseline and Day 42. The questionnaire on Day 56 will mark the conclusion of the trial.
Conditions
Interventions
- OTHER
-
EQ Exfoliating Cleanser
Product contains: Purified water, disodium laureth sulfosuccinate, coco betaine, decyl glucoside, Juglans regia (walnut) shells, PEG-40 hydrogenated castor oil, sodium cocoyl isethionate disodium cocoyl glutamate, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), Aloe barbadensis (aloe vera) leaf juice concentrate (Aloe barbadensis leaf juice, potassium sorbate, sodium benzoate, citric acid).
- OTHER
-
EQ Gel
Product contains: Purified water, witch hazel (containing 14% grain alcohol), PEG-40 hydrogenated castor oil, ethoxydiglycol, xanthan gum, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), xanthan gum.
- OTHER
-
EQ Moisturizer
Product contains: Purified water, glycerin, dicaprylyl carbonate, cetyl alcohol, glyceryl stearate citrate, squalane, PEG-40 hydrogenated castor oil, caprylic/capric triglycerides, stearic acid, jojoba oil, phenoxyethanol SA (phenoxyethanol, caprylyl glycol, sorbic acid), ethoxydiglycol, Root Blend Preservative (hexylene glycol, caprylyl glycol, Wasabia japonica (wasabi) root extract, Zingiber officinale (ginger) root extract, Allium sativum (garlic) bulb extract), allantoin, sodium carbomer.
Sponsors & Collaborators
-
Citruslabs
collaborator INDUSTRY -
Menning Labs
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-02
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne
NCT02293018 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Emulsion 8-Week Anti-acne Efficacy Clinical Study
NCT06985745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne
NCT03124381 ·Status: COMPLETED ·Phase: NA
-
Effect of New Topical Preparation for Treatment of Acne Vulgaris
NCT05899699 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
NCT04214639 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne
NCT05446402 ·Status: COMPLETED ·Phase: PHASE4
-
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
NCT01446237 ·Status: COMPLETED ·Phase: NA
-
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
NCT03170388 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
NCT03664739 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris
NCT06671834 ·Status: COMPLETED ·Phase: PHASE1
-
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT00926367 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
NCT02698436 ·Status: COMPLETED ·Phase: NA
-
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
NCT01209949 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
NCT04329403 ·Status: WITHDRAWN ·Phase: PHASE3
-
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel
NCT02946788 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne
NCT03450369 ·Status: COMPLETED ·Phase: PHASE1
-
Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
NCT03122457 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin
NCT05941065 ·Status: RECRUITING ·Phase: NA
-
Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.
NCT03106766 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes
NCT02709096 ·Status: COMPLETED ·Phase: PHASE2
-
Experience With Topical Acne Treatment
NCT05582434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne
NCT00776919 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
NCT02005666 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy Evaluation of a Skincare Product for Acne Face, Upper Chest and Back Used by Multiphototype Population Under Dermatological Control
NCT06786442 ·Status: COMPLETED ·Phase: NA
-
Cutaneous Acceptability, Comedogenic Potential and Efficacy of Two Cosmetic Products Used in Synergy
NCT05490537 ·Status: COMPLETED